Health & FitnessMedicineScienceLife SciencesChemistry

CPHI Podcast Series

Informa Markets

The CPHI Podcast Series is your new monthly pharma soundbite, bringing you insights from across the global value chain. Through drug discovery and development to manufacturing and delivery, we’ll bring you impactful content to keep you informed on the latest trends, developments, and opportunities in Pharma.

Brought to you by the organisers of the CPHI and Pharmapack exhibitions, the series is an easy way to stay up to date on the issues which matter to your business. Tune in to hear from key industry stakeholders sharing easy-to-digest insights – the CPHI Podcast Series is your trusted voice in pharma.

Play

Open in

20 episodes
monthly
Avg 28 min
English

Episodes 20

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

#67
June 12 · 23 min
Predictive technology for critical storage
In this episode of the CPHI Podcast Series, Editor Vivian Xie speaks to John and Laurie Masiello, co-founders of Predictive Monitor, as they discuss their journey in developing predictive maintenance and detection solutions for the life sciences and biopharma industries. Their debut product, Overshield, provides a practical solution to replace scheduled and reactive maintenance of refrigerated chamber systems, helping their clients protect and deliver life-saving products to the patients that need it most.
#66
February 13 · 19 min
Stevanato Group shares packaging insights from Pharmapack 2026
In this special live episode of the CPHI Podcast Series, recorded at Pharmapack 2026, we have an engaging conversation between David Roach (Dr Creative) and Terry O’Hagan of Stevanato Group. With over two decades of expertise in medical device development, O’Hagan shares how Stevanato Group leads the way in pharmaceutical packaging innovation, leveraging its glass manufacturing heritage, automation, and strategic collaborations. Discover how the company enhances drug delivery systems, adapts to regional needs, and navigates market challenges to improve patient outcomes and drive industry growth.
#65
Nov 24, 2025 · 18 min
CPHI Frankfurt special – the future of health
Welcome to this special on-site episode of our podcast, recorded live at CPHI Frankfurt 2025, the premier global event for the pharmaceutical industry. In this episode, Editor Vivian Xie speaks to Sabine Kapasi, global health strategist, entrepreneur, and CEO of Enira Consulting. This year’s gathering brought together thought leaders, innovators, and policymakers to discuss the most pressing issues and transformative trends shaping the future of healthcare, the following episode encapsulates the key themes that were discussed at CPHI Frankfurt.
#64
Oct 20, 2025 · 34 min
From Patents to Public Health: The GLP-1 Journey
In this insightful episode, host Lucy Chard is joined by Aurelio Arias from IQVIA to explore the transformative role of GLP-1 therapies in clinical obesity treatment and the technological advancements driving their success. Aurelio delves into how these medications are revolutionising care, offering hope to millions worldwide. A key focus is the upcoming patent expiry of semaglutide in 2026, which could significantly impact affordability and global access, sparking discussions on equitable distribution.
#63
Sep 29, 2025 · 35 min
AI transforming pharma manufacturing
In this episode, host Lucy Chard and guest David Staunton of Cognizant dive into the transformative role of AI in the pharmaceutical industry, exploring advancements that are reshaping manufacturing, packaging, and distribution. From the rise of "smart factories" to the seamless integration of AI across specialised production processes, we discuss how technology is accelerating innovation and what the future holds for pharma in the next decade.
#62
Aug 18, 2025 · 30 min
Achieving global health equity through innovation
In the latest episode Lucy Chard engages in a compelling conversation with Dr Lengwe Sinkala, a seasoned clinician and Human Factors and User Experience Consultant at ClariMed. The discussion delves into the disparities in global access to medical devices, highlighting the stark differences between developed and developing regions. Tune in to the CPHI Podcast Series to hear Dr Sinkala’s inspiring insights and explore how we can collectively work towards a more equitable healthcare landscape.
#60
Jun 9, 2025 · 33 min
US drug policy – exploring the executive orders
In this key episode, Digital Editor Lucy Chard is joined by Dr Molly Klote, former Director of the US Department of Health and Human Services Office for Human Research Protections. Molly sheds some light on the policy changes we have witnessed over the past few years in the US, including the latest executive orders regarding the ‘Most Favoured Nation’ policy whereby the US government aims to slash drug prices to match those of other developed countries.
#59
Apr 14, 2025 · 26 min
Fulfilling an unmet need for rare disease patients
This episode covers how the pharmaceutical industry can work towards better meeting the needs of an underserved population. Rare diseases are often overlooked by pharmaceutical companies when developing drugs as the process is time consuming, expensive, and only serves a niche market. But the patients suffering from rare diseases still deserve to have the best opportunity for life changing medicine. Dea Belazi from AscellaHealth discusses the challenges in this field, and the exciting paths into the future.
#58
Mar 10, 2025 · 26 min
How to build a successful CDMO partnership
In this podcast Christine Furst, Senior Director Key Account Management Europe from Vetter joins host Lucy Chard to discuss the relationship between pharma companies and CDMOs and the impacts this relationship has on a business’s vision for the future. Taking into consideration that although the practical and technical aspects have to line up, more and more partnerships are placing value in the corporations seeing ‘eye to eye’ because they want the relationship to grow and flourish. We touch on the importance of people, sustainability and values aligning for building successful partnerships.
#57
Feb 12, 2025 · 12 min
Packaging expert perspectives at Pharmapack 2025
This month's podcast episode sounds a little different, covering the latest event in Paris - Pharmapack 2025. Digital Editor Lucy Chard speaks to several experts direct from the floor of the show, bringing you right in on the action. In this special episode we hear from experts Tom Etheridge from Team Consulting, Lizzie Smith from Anthesis Group, Asmita Khanolkar from SMC Ltd, and our very own Sherma Ellis Daal from Informa Markets to give a few different perspectives on some aspects of the event and the industry as a whole.
#56
Jan 15, 2025 · 31 min
What does an evolving pharmaceutical industry mean for excipients?
In this episode, Evonne Brennan joined host Lucy Chard for a chat about the complex world of excipients. Excipients is an ever changing field that involves a lot of moving parts and in the following episode Evonne gave an insight into some of these aspects. The podcast covers the security of the excipient supply chain and how this can influence issues such as drug pricing and drug shortages. Brennan highlights how important communication and collaboration is in this field for education and for pushing to find the next target for progress, that ultimately will make the lives of patients better.
#55
Dec 4, 2024 · 32 min
Investing in a vision for the future of life sciences
In this episode Lucy Chard is joined by Rajiv Khatau to discuss the importance of looking into new therapeutic areas and some of the more niche areas of pharmaceuticals, discussing innovations and the potential for shaping the future of pharma on a global scale. In particular, and in light of the lead up to the inaugural CPHI Middle East in December 2024, Rajiv shares his expertise on the Middles East market and comments on why this region is so well suited to pushing the boundaries and becoming a leader in areas of biotech, genomics, and other public health fields.
#54
Sep 16, 2024 · 37 min
The power of proteins in antibody drug development
In the latest episode Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. Tom gives an insight into the world of protein engineering, how it’s an invaluable tool for improving the stability, functionality, and applicability for drug products. He comments on some aspects of the field that are particularly exciting at the minute, discussing some of the key aspects of antibody drugs, the potential for bispecifics in improving functionality, but also considering the parts such as genomics for creating a wider knowledge base, and in the future using computational design and AI to develop drugs more safely.
#53
Aug 13, 2024 · 33 min
Why we need to consider women in clinical trials
Lucy Chard, Digital Editor for CPHI Online discusses womens’ health, and more specifically about women’s representation in clinical trials and the associated ripple effects with Emma Banks, CEO of Ramarketing. The podcast highlights the social and medical implications and bias’ that lead to disparity and the complexities around this. Also covered is the need for solutions in combatting bias, such as by using tools including education and technology, and cross-sector collaboration. Banks highlighted how important it is to acknowledge the differences and work with them to change the lived mindset and make safer, more effective medicines.
#52
Jul 16, 2024 · 28 min
Analysing ESG Audits with the PSCI
In this episode we’re focusing on some of the work from one of our valued partners at CPHI, the PSCI. The PSCI have recently published the results from their audits and to talk us through these Digital Editor Lucy Chard is joined by Birgit Skuballa. Skuballa represents Bayer in the PSCI as Chair of the PSCI Audit Committee, and gives us a information on how these audits work, the different pillars across the pharmaceutical industry that the audits address, how this changes regionally, and importantly, how the PSCI work with their members afterwards to improve their practices.
#51
Jun 26, 2024 · 38 min
The power of digital marketing in pharma
On this episode of the podcast I’m joined my marketing specialist and entrepreneur, Raman Sehgal. Sehgal is the founder of several companies, including life science marketing company Ramarketing. In this podcast Raman and I discuss the different ways marketing can help companies in achieving their goals, whether it’s in how to go about finding the right partner, creating the right messaging around a companies’ ESG values, or how to attract talent. We also go on to talk about the future of digital marketing, especially the increased use of AI in today’s world, how much this has changed everyday practices already, and the scope of what is to come.
#50
Mar 27, 2024 · 27 min
How manufacturing in Africa can improve patient access to medicine
Daniel Mora-Brito joins Lucy Chard to discuss the health landscape in the African continent, covering some of the greatest threats seen there over the years and that are still impacting people’s lives on a daily basis, helping to drive home the importance of improved, localised healthcare in the continent. Lucy and Daniel talk about the economic factors that underpin a lot of the transformations across the region, from the perspective of those on home turf and the companies from different regions looking to invest and expand into this space. Daniel mentions the different actors in the region and what expanding capacities in Africa will mean for patient access in a rapidly expanding population.
#49
Feb 28, 2024 · 31 min
What to expect from novel excipients?
This podcast episode aims to explain the importance and intricacies of developing excipients and then goes into more depth regarding the excipient market, how this differs globally, what tactics different companies are now using to gain ground and push the field forward to be able to develop more innovative drug delivery systems. Digital Editor Lucy Chard is joined by Nick DiFranco, MEM, the Global Market Manager for Novel Pharmaceutical Excipients at Lubrizol Life Science. Lubrizol is a pioneer in the novel excipient development space so DiFranco can give a deep level of insight into the field as it stands, some of the innovative products they’re developing at Lubrizol, and the trends to look out for the in future.
#48
Dec 18, 2023 · 30 min
The 2023 Retro – what have we learnt from the past year in pharma?
Welcome to the last episode of 2023! Digital Editor Lucy Chard is joined by her team in a special retrospective episode to close out the year. Guests Vivian Xie, Editor for CPHI Online and Tara Dougal, Content Director for Pharma, discuss their highlights from the year; diversity, sustainability, and the CPHI Barcelona event cropping up as top features. The Women in Pharma series that Vivian has worked on for the past year has been a resounding success, some of our most impactful content on CPHI Online, which, as arguably some of our most important content we are so pleased to see that reflected with our audience. We also cover sustainability, drug approvals, Alzheimer's research, mRNA oncology vaccines, and digital marketing for pharma companies. To see more about everything we mentioned in the podcast, see the links below: Women in Pharma Interviews Women in Pharma: Advancing gender diversity & healthcare equality - https://www.cphi-online.com/women-in-pharma-advancing-gender-diversity-news121441.html Women in Pharma: Empowering yourself and other women in pharma - https://www.cphi-online.com/women-in-pharma-empowering-yourself-and-other-news122294.html Sustainability CPHI Sustainability Trend Report 2023: Towards a Greener Future - https://www.cphi-online.com/cphi-sustainability-trend-report-2023-towards-a-news121332.html CPHI Podcast Series: An insight into the Chief Sustainability Officer - https://www.cphi-online.com/cphi-podcast-series-an-insight-into-the-chief-news120741.html CPHI Podcast Series: Sustainable Strategies in the Pharmaceutical Packaging Industry - https://www.cphi-online.com/cphi-podcast-series-sustainable-strategies-in-the-news119779.html Top Content Your Prescription for Marketing Success: Digital Pharma Marketing Toolkit – Free eBook - https://www.cphi-online.com/your-prescription-for-marketing-success-digital-news121086.html 10 Major Drug Approvals So Far in 2023 - https://www.cphi-online.com/10-major-drug-approvals-so-far-in-2023-news121294.html CPHI Podcast Series: Exploring neurological frontiers in Alzheimer's and beyond - https://www.cphi-online.com/cphi-podcast-series-exploring-neurological-news122273.html The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner - https://www.cphi-online.com/the-cpo-starter-pack-why-and-when-to-bring-in-a-news120889.html Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity - https://www.cphi-online.com/ashwagandha-and-herbal-medicines-pharma-s-next-news122695.html The Patient-Centric Synergy of Pharmaceutical CDMO and CRO Collaborations - https://www.cphi-online.com/the-patient-centric-synergy-of-pharmaceutical-news122510.html Delivering on mRNA-based therapeutics: innovations in applications and packaging - https://www.cphi-online.com/delivering-on-mrna-based-therapeutics-innovations-news121217.html Upcoming 2024 Pharma Trends Outlook: Collaboration, Market Maturity, and Digital Futures for Pharma Pharmapack 2024 - https://www.pharmapackeurope.com/en/home.html CPHI Webinar Series - Innovative Strategies for B2B Pharma Marketeers: Driving Value through Content – 20th February 2024 4pm CET Sustainability report 2024 CPHI Milan 2024 - https://europe.cphi.com/europe/en/home.html
#47
Dec 4, 2023 · 17 min
Start-ups take centre stage at CPHI Barcelona
In this special post-CPHI Barcelona episode, host Lucy Chard speaks to Matthew Wise from CCD Partners about the Start-up Market held at the event. In this podcast they speak about the event, which for the first time held a specific area for Start-up companies, something that is particularly applicable to the Catalan region as a leading area for innovation in pharma and healthcare, they also talk about discuss what this start-up market means for the companies, as well as for investors and potential partners, and for the future of pharma innovation.

Showing 1–20 of 20 episodes